
Rei Tsang Shiao
Examiner (ID: 13461, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9206207
[patent_doc_number] => 20140005384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid'
[patent_app_type] => utility
[patent_app_number] => 14/016839
[patent_app_country] => US
[patent_app_date] => 2013-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 15558
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016839
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016839 | Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid | Sep 2, 2013 | Issued |
Array
(
[id] => 9263534
[patent_doc_number] => 20130345463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE'
[patent_app_type] => utility
[patent_app_number] => 14/013966
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21442
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013966
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013966 | Process for preparing malathion for pharmaceutical use | Aug 28, 2013 | Issued |
Array
(
[id] => 11009643
[patent_doc_number] => 20160206597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'New Use'
[patent_app_type] => utility
[patent_app_number] => 14/914029
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914029
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914029 | New Use | Aug 25, 2013 | Abandoned |
Array
(
[id] => 9602688
[patent_doc_number] => 20140199370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'CYCLODEXTRIN-BASED MATERIALS COMPOSITIONS AND USES RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/968112
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24689
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/968112 | CYCLODEXTRIN-BASED MATERIALS COMPOSITIONS AND USES RELATED THERETO | Aug 14, 2013 | Abandoned |
Array
(
[id] => 9294135
[patent_doc_number] => 20140037769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'METHOD FOR MANUFACTURING PURE GUAR FLOUR'
[patent_app_type] => utility
[patent_app_number] => 13/960890
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7697
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960890
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960890 | METHOD FOR MANUFACTURING PURE GUAR FLOUR | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9951244
[patent_doc_number] => 09000031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Thioxanthone-based autophagy inhibitor therapies to treat cancer'
[patent_app_type] => utility
[patent_app_number] => 13/960281
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 15877
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960281 | Thioxanthone-based autophagy inhibitor therapies to treat cancer | Aug 5, 2013 | Issued |
Array
(
[id] => 9162121
[patent_doc_number] => 20130310398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Combination therapy for the treatment of diabetes and related conditions'
[patent_app_type] => utility
[patent_app_number] => 13/949579
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14908
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13949579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/949579 | Combination therapy for the treatment of diabetes and related conditions | Jul 23, 2013 | Abandoned |
Array
(
[id] => 9530362
[patent_doc_number] => 08754236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Compounds for preparing immunological adjuvant'
[patent_app_type] => utility
[patent_app_number] => 13/947593
[patent_app_country] => US
[patent_app_date] => 2013-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20464
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/947593 | Compounds for preparing immunological adjuvant | Jul 21, 2013 | Issued |
Array
(
[id] => 9149218
[patent_doc_number] => 20130303741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES'
[patent_app_type] => utility
[patent_app_number] => 13/944956
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5206
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944956 | Process for the preparation of enantiomerically pure amines | Jul 17, 2013 | Issued |
Array
(
[id] => 11721167
[patent_doc_number] => 09694014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/942448
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8833
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/942448 | Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors | Jul 14, 2013 | Issued |
Array
(
[id] => 9122153
[patent_doc_number] => 20130289075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'IAP BINDING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/926283
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41468
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/926283 | IAP binding compounds | Jun 24, 2013 | Issued |
Array
(
[id] => 9122120
[patent_doc_number] => 20130289042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'DIMERIC IAP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/925960
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32718
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/925960 | Dimeric IAP inhibitors | Jun 24, 2013 | Issued |
Array
(
[id] => 9263276
[patent_doc_number] => 20130345205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'SUBSTITUTED BICYCLIC ARALKYL PYRAZOLE LACTAM ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/922229
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 76227
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922229 | SUBSTITUTED BICYCLIC ARALKYL PYRAZOLE LACTAM ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | Jun 18, 2013 | Abandoned |
Array
(
[id] => 10876340
[patent_doc_number] => 08901125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors'
[patent_app_type] => utility
[patent_app_number] => 13/922230
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 75994
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922230
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922230 | Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors | Jun 18, 2013 | Issued |
Array
(
[id] => 9263274
[patent_doc_number] => 20130345204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'SUBSTITUTED BICYCLIC CYCLOALKYL PYRAZOLE LACTAM ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/922225
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 63546
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922225
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922225 | SUBSTITUTED BICYCLIC CYCLOALKYL PYRAZOLE LACTAM ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | Jun 18, 2013 | Abandoned |
Array
(
[id] => 9869329
[patent_doc_number] => 08957101
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-02-17
[patent_title] => 'Amino acid compositions'
[patent_app_type] => utility
[patent_app_number] => 13/920076
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12744
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920076
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920076 | Amino acid compositions | Jun 16, 2013 | Issued |
Array
(
[id] => 10095822
[patent_doc_number] => 09132117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Compositions and methods for glycemic control of subjects with impaired fasting glucose'
[patent_app_type] => utility
[patent_app_number] => 13/919589
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8991
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919589
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/919589 | Compositions and methods for glycemic control of subjects with impaired fasting glucose | Jun 16, 2013 | Issued |
Array
(
[id] => 9850316
[patent_doc_number] => 08952045
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-02-10
[patent_title] => 'Amino acid compositions'
[patent_app_type] => utility
[patent_app_number] => 13/920070
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12759
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920070 | Amino acid compositions | Jun 16, 2013 | Issued |
Array
(
[id] => 9850318
[patent_doc_number] => 08952046
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-02-10
[patent_title] => 'Amino acid compositions'
[patent_app_type] => utility
[patent_app_number] => 13/920081
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12751
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920081
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920081 | Amino acid compositions | Jun 16, 2013 | Issued |
Array
(
[id] => 9869328
[patent_doc_number] => 08957100
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-02-17
[patent_title] => 'Amino acid compositions'
[patent_app_type] => utility
[patent_app_number] => 13/920066
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12744
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920066
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920066 | Amino acid compositions | Jun 16, 2013 | Issued |